Application Nr Approved Date Route Status External Links
ANDA202323 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Carbidopa And Levodopa Extended-Release Tablets Are Indicated In The Treatment Of Parkinson's Disease, Post-Encephalitic Parkinsonism, And Symptomatic Parkinsonism That May Follow Carbon Monoxide Intoxication Or Manganese Intoxication.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Name Structure ZINC ID(s)
1. Carbidopa CARBIDOPA ZINC19168887
2. Levodopa LEVODOPA ZINC895199

Comments